NCT06566742 : Clinical Trial Detail - Cancer Knowledgebase (CKB)

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

NCT ID	NCT06566742
Title	A Phase 2 Study Evaluating Olutasidenib in Patients With IDH1-mutated Clonal Cytopenia of Undetermined Significance and Lower-risk Myelodysplastic/Syndromes/Chronic Myelomonocytic Leukemia.
Recruitment	Recruiting
Gender	both
Phase	Phase II
Variant Requirements	Yes
Sponsors	M.D. Anderson Cancer Center
Indications	chronic myelomonocytic leukemia myelodysplastic syndrome
Therapies	Olutasidenib
Age Groups:	adult \| senior
Covered Countries	USA

Facility	Status	City	State	Zip	Country	Details
University of Miami	RECRUITING	Miami	Florida	33136	United States	Details
MD Anderson Cancer Center	RECRUITING	Houston	Texas	77030	United States	Details

*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field

NCT06566742Clinical Trial Detail